Stockreport

Abivax releases the results of its May 30, 2024 Ordinary and Extraordinary General Meeting

Abivax SA  (ABVX) 
PDF PARIS, France, June 4, 2024 – Abivax SA (Euronext Paris & Nasdaq: ABVX) (“Abivax” or the “Company”), a clinical-stage biotechnology company focused on developing the [Read more]